KAPA Kairos Pharma, LTD.
NYSE · SEC CIK 1962011 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 13 since 2024-11-21, latest 2025-12-30
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Samuelson Doug | CFO | — | — |
| Bhowmick Neil | CSO | — | — |
| Murali Ramachandran | VP of Research, Development | — | — |
| Yu John S | CEO, COB, Dir, 10% | — | — |
| Singhvi Rahul | Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-30 | 2025-10-08 | KAPA | Bhowmick Neil | CSO | A - Grant | $0.00 | +171.8K | 1.31M | +15% | $0 | |
| M | 2025-12-23 | 2025-09-16+ | KAPA | Bae Hyun W. | Dir | A - Grant | $0.00 | +29.1K | 54.3K | +115% | $0 |
| 2025-11-26 | 2025-10-08 | KAPA | Yu John S | CEO, COB, Dir, 10% | A - Grant | $0.00 | +190.8K | 230.1K | +486% | $0 | |
| 2025-11-26 | 2025-10-08 | KAPA | Murali Ramachandran | VP of Research, Development | A - Grant | $0.00 | +152.7K | 299.5K | +104% | $0 | |
| 2025-11-26 | 2025-10-08 | KAPA | Samuelson Doug | CFO | A - Grant | $0.00 | +152.7K | 293.0K | +109% | $0 | |
| M | 2025-11-26 | 2025-09-16+ | KAPA | Keyoung Hansoo Michael | Dir | A - Grant | $0.00 | +29.1K | 29.1K | New | $0 |
| 2025-11-26 | 2025-10-08 | KAPA | Singhvi Rahul | Dir | A - Grant | $0.00 | +19.1K | 49.2K | +63% | $0 | |
| 2025-04-07 | 2025-01-01 | KAPA | Bhowmick Neil | CSO | A - Grant | $0.00 | +14.0K | 1.14M | +1% | $0 | |
| 2025-02-24 | 2025-01-01 | KAPA | Murali Ramachandran | VP of Research, Development | A - Grant | $0.00 | +14.0K | 147.1K | +11% | $0 | |
| 2025-02-24 | 2025-01-01 | KAPA | Yu John S | CEO, COB, Dir, 10% | A - Grant | $0.00 | +14.0K | 5.36M | +0.3% | $0 | |
| 2024-11-25 | 2024-11-25 | KAPA | Murali Ramachandran | VP of Research, Development | P - Purchase | $1.59 | +200 | 133.1K | +0.2% | +$318 | |
| 2024-11-25 | 2024-11-22 | KAPA | Samuelson Doug | CFO | P - Purchase | $1.50 | +2,500 | 60.8K | +4% | +$3,750 | |
| 2024-11-21 | 2024-11-20 | KAPA | Yu John S | CEO, COB, Dir, 10% | P - Purchase | $1.44 | +4,000 | 5.34M | +0.1% | +$5,760 |
Purchase Sale Sale after option exercise All abbreviations